The Role of Cost-Effectiveness Analysis in Precision Medicine and Public Health Genomics
March 27, 2018, 10:00-11:30 am EST
CDC Chamblee Campus, Chamblee Campus Bldg 102 RM 2202
- Whiting P et al. Ivacaftor for the treatment of patients with cystic fibrosis and the G551D mutation: a systematic review and cost-effectiveness analysis. Health Technol Assess. 2014 Mar;18(18):1-106
- Grosse SD, Khoury MJ. Epidemiology matters: peering inside the “black box” in economic evaluations of genetic testing. Genet Med. 2016 Oct;18(10):963-5.